Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.2B; returns 1 day -3.7%, 1 week +4.0%, 1 year -41.5%.

Nektar Therapeutics is a clinical-stage biopharmaceutical company focused on discovering and developing novel drug candidates, primarily through its immunology platform.

Groups NKTR belongs to

• Biotechnology
• Clinical Stage Biopharma
• Healthcare
• Clinical Stage
• Immunotherapy
• Autoimmune Diseases
• Life Sciences
• Dermatology
• Alopecia Areata

NKTR financial model: income statement, cash flow and balance sheet